Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
John Celebi | PRESIDENT AND CEO | 2025-02-19 | 5,558 | $0.48 | $2.65kSell |
Der Horst Edward Van | CHIEF SCIENTIFIC OFFICER | 2025-02-19 | 2,276 | $0.48 | $1.08kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
James Peyer | 700.99% | 8,841,457 | $99.02M | Insider |
Hs Investments I LP | 350.91% | 4,425,998 | $49.57M | Insider |
Cambrian Biopharma Inc | 289.63% | 3,653,120 | $40.91M | Insider |
Thomas G. Ricks | 54.36% | 685,632 | $7.68M | Insider |
John Celebi | 8.39% | 105,862 | $1.19M | Insider |
Robert Hamilton Pierce | 7.49% | 94,463 | $1.06M | Insider |
Erin Colgan | 5.35% | 67,462 | $755.57k | Insider |
Der Horst Edward Van | 4.74% | 59,794 | $669.69k | Insider |
Patrick Stephen Gallagher | 2.71% | 34,130 | $382.26k | Insider |
Vanguard Group Inc | 2.31% | 29,090 | $325.81k | Institution |